drugset / Trial / NCT00068913
Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
Phase 2
Unknown
35 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
RandomizedCrossoverDouble-blindTreatment
Summary
Patients with the MELAS syndrome experience devastating mental impairment. This study will evaluate the effectiveness of the drug dichloroacetate (DCA) to reduce the symptoms of MELAS.
Timeline
- Start
- 2000-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DICHLOROACETIC ACID | Small molecule | — | — |